SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-065276
Filing Date
2006-03-28
Accepted
2006-03-28 17:03:34
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2005 d10k.htm 10-K 1103166
2 AGREEMENT BETWEEN REGISTRANT AND AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO dex1010.htm EX-10.10 78923
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1785
4 CEO CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex311.htm EX-31.1 9193
5 CFO CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex312.htm EX-31.2 9167
6 CEO CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 4377
7 CFO CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 4541
  Complete submission text file 0001193125-06-065276.txt   1212556
Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51136 | Film No.: 06715731
SIC: 2834 Pharmaceutical Preparations